Abstract

It has been documented that reactive oxygen species (ROS) contribute to oxidative stress, leading to diseases such as ischemic heart disease. Recently, increasing evidence has indicated that short-term intermittent hypoxia (IH), similar to ischemia preconditioning, could yield cardioprotection. However, the underlying mechanism for the IH-induced cardioprotective effect remains unclear. The aim of this study was to determine whether IH exposure can enhance antioxidant capacity, which contributes to cardioprotection against oxidative stress and ischemia/reperfusion (I/R) injury in cardiomyocytes. Primary rat neonatal cardiomyocytes were cultured in IH condition with an oscillating O2 concentration between 20% and 5% every 30 min. An MTT assay was conducted to examine the cell viability. Annexin V-FITC and SYTOX green fluorescent intensity and caspase 3 activity were detected to analyze the cell death. Fluorescent images for DCFDA, Fura-2, Rhod-2, and TMRM were acquired to analyze the ROS, cytosol Ca2+, mitochondrial Ca2+, and mitochondrial membrane potential, respectively. RT-PCR, immunocytofluorescence staining, and antioxidant activity assay were conducted to detect the expression of antioxidant enzymes. Our results show that IH induced slight increases of O2−· and protected cardiomyocytes against H2O2- and I/R-induced cell death. Moreover, H2O2-induced Ca2+ imbalance and mitochondrial membrane depolarization were attenuated by IH, which also reduced the I/R-induced Ca2+ overload. Furthermore, treatment with IH increased the expression of Cu/Zn SOD and Mn SOD, the total antioxidant capacity, and the activity of catalase. Blockade of the IH-increased ROS production abolished the protective effects of IH on the Ca2+ homeostasis and antioxidant defense capacity. Taken together, our findings suggest that IH protected the cardiomyocytes against H2O2- and I/R-induced oxidative stress and cell death through maintaining Ca2+ homeostasis as well as the mitochondrial membrane potential, and upregulation of antioxidant enzymes.

Highlights

  • Obstructive sleep apnea (OSA), known as intermittent hypoxia (IH), is characterized by repetitive episodic obstructions of airflow during sleep [1]

  • It has been demonstrated that the activities of L-type Ca2+ channel (LTCC), ryanodine receptors (RyR), sarcoplasmic/endoplasmic reticulum Ca2+ -ATPase (SERCA) and phospholamban were regulated by Ca2+ /calmodulin-dependent kinase II (CaMKII) and cAMP-dependent protein kinase A (PKA), and these proteins have been demonstrated to be involved in regulating intracellular Ca2+ homeostasis under physiological and pathophysiological conditions [11,12]

  • We demonstrated that IH4 attenuated the H2O2-induced cytosolic and mitochondrial Ca2+ overload through reactive oxygen species (ROS) production, thereby preventing mitochondrial membrane depolarization

Read more

Summary

Introduction

Obstructive sleep apnea (OSA), known as intermittent hypoxia (IH), is characterized by repetitive episodic obstructions of airflow during sleep [1]. Several mechanisms have been proposed to be involved in the IH-induced protective effects, including activation of hypoxia-responsive genes, amelioration of coronary circulation, activation of protein kinase C, balance of Ca2+ handling activity, and inhibition of mitochondrial permeability transition pores (mPTP) opening [6,7,8,9,10]. ROS has been demonstrated to regulate other signaling molecules or channels, including protein tyrosine kinase, MAP kinase, phospholipase c (PLC), NFκB, IP3 receptor, ryanodine receptor, and Na+ /Ca2+ exchanger (NCX) [16].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call